research use only
Cat.No.S7101
| Related Targets | p38 MAPK Raf JNK MEK Ras KRas S6 Kinase MAP4K TAK1 Mixed Lineage Kinase |
|---|---|
| Other ERK Inhibitors | Ravoxertinib (GDC-0994) Ulixertinib (BVD-523) LY3214996 (Temuterkib) FR 180204 VX-11e XMD8-92 AZD0364 (ATG-017) ERK5-IN-1 Senkyunolide I Astragaloside IV |
|
In vitro |
DMSO
: 14 mg/mL
(23.82 mM)
Water : Insoluble Ethanol : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about SCH772984 working concentrations for cell culture treatment
| Information | SCH772984 is a highly selective and potent ERK1/2 inhibitor. It affects the MAPK/ERK signaling pathway by blocking ERK phosphorylation and its downstream targets, effectively inhibiting tumor cell proliferation, migration, and invasion, and promoting apoptosis. |
|---|---|
|
Read more about SCH772984 IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
| Molecular Weight | 587.67 | Formula | C33H33N9O2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 942183-80-4 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1CN(CC1C(=O)NC2=CC3=C(C=C2)NN=C3C4=CC=NC=C4)CC(=O)N5CCN(CC5)C6=CC=C(C=C6)C7=NC=CC=N7 | ||
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
I would like to inhibit Erk1/2 by treating the mice with it. By what kind of administration way and at what concentration could this compound be used?
Answer:
It can be administered by I.P. The dosages can be used as: 12.5 mg/kg, 25 mg/kg, 50 mg/kg. For more detailed information please find the paper below: http://cancerdiscovery.aacrjournals.org/content/3/7/742.full